Expression of flotillin-2 in human non-small cell lung cancer and its correlation with tumor progression and patient survival

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 1, 2015, Pages 601-607

  Wang, Yong Lian ^a   Yao, Wen Jian ^a   Guo, Ling ^a   Xi, Hui Fang ^a   Li, Song Yue ^a   Wang, Zhong Min ^a  

^a The Third Hospital of Xinxiang Medical University   (China)

Author keywords

FLOT2; Lung cancer; Non small cell lung cancer; Prognosis

Indexed keywords

FLOTILLINS; MEMBRANE PROTEIN; TUMOR MARKER;

ADULT; AGED; DISEASE COURSE; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; MORTALITY; NON SMALL CELL LUNG CANCER; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ADULT; AGED; BIOMARKERS, TUMOR; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 84923087128     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Siegel R, Naishadham D and Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11-30.
2. Dussek JE. Surgical management of lung cancer. Cancer Imaging 2000; 1: 35-43.
3. Goldstraw P, Ball D, Jett JR, Le Chevalier T, Lim E, Nicholson AG and Shepherd FA. Non-small-cell lung cancer. Lancet 2011; 378: 1727-1740.
4. Salzer U and Prohaska R. Stomatin, flotillin-1, and flotillin-2 are major integral proteins of erythrocyte lipid rafts. Blood 2001; 97: 1141-1143.
5. Stuermer CA. Reggie/flotillin and the targeted delivery of cargo. J Neurochem 2011; 116: 708-713.
6. Munderloh C, Solis GP, Bodrikov V, Jaeger FA, Wiechers M, Malaga-Trillo E and Stuermer CA. Reggies/flotillins regulate retinal axon regeneration in the zebrafish optic nerve and differentiation of hippocampal and N2a neurons. J Neurosci 2009; 29: 6607-6615.
7. Meister M and Tikkanen R. Endocytic trafficking of membrane-bound cargo: a flotillin point of view. Membranes (Basel) 2014; 4: 356-371.
8. Rajendran L, Beckmann J, Magenau A, Boneberg EM, Gaus K, Viola A, Giebel B and Illges H. Flotillins are involved in the polariza tion of primitive and mature hematopoietic cells. PLoS One 2009; 4: e8290.
9. Kokubo H, Lemere CA and Yamaguchi H. Localization of flotillins in human brain and their accumulation with the progression of Alzheimer's disease pathology. Neurosci Lett 2000; 290: 93-96.
10. Wang X, Yang Q, Guo L, Li XH, Zhao XH, Song LB and Lin HX. Flotillin-2 is associated with breast cancer progression and poor survival outcomes. J Transl Med 2013; 11: 190.
11. Cao K, Xie D, Cao P, Zou Q, Lu C, Xiao S, Zhou J and Peng X. SiRNA-mediated flotillin-2 (Flot2) downregulation inhibits cell proliferation, migration, and invasion in gastric carcinoma cells. Oncol Res 2014; 21: 271-279.
12. Yan Y, Yang FQ, Zhang HM, Che J and Zheng JH. Up-regulation of flotillin-2 is associated with renal cell carcinoma progression. Tumour Biol 2014; 35: 10479-86.
13. Berger T, Ueda T, Arpaia E, Chio II, Shirdel EA, Jurisica I, Hamada K, You-Ten A, Haight J, Wakeham A, Cheung CC, Mak TW. Flotillin-2 deficiency leads to reduced lung metastases in a mouse breast cancer model. Oncogene 2013; 32: 4989-4994.
14. Hazarika P, McCarty MF, Prieto VG, George S, Babu D, Koul D, Bar-Eli M and Duvic M. Up-regulation of Flotillin-2 is associated with melanoma progression and modulates expression of the thrombin receptor protease activated receptor 1. Cancer Res 2004; 64: 7361-7369.
15. Doherty SD, Prieto VG, George S, Hazarika P and Duvic M. High flotillin-2 expression is associated with lymph node metastasis and Breslow depth in melanoma. Melanoma Res 2006; 16: 461-463.
16. Egner JR. AJCC cancer staging manual. JAMA 2010; 304: 1726-1727.
17. Molina R, Filella X and Auge JM. ProGRP: a new biomarker for small cell lung cancer. Clin Biochem 2004; 37: 505-511.
18. Shivakumar L, Cummings C, Katz J, Sullivan T, Wiley SR, Ann Glauser T, Cerenzia W and Williamson C. The Role of Histology and Molecular Markers in NSCLC. Oncology Issues 2012; 27: 38
19. Valastyan S and Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell 2011; 147: 275-292.